(Alliance News) - London's FTSE 100 is set to open in an underwhelming fashion on Friday, after falls in New York and Asia on US economic nerves. Read More
(Alliance News) - GSK PLC on Thursday said the US Food & Drug Administration expanded the use of its cancer medicine Jemperli, also known as dostarlimab, when combined with chemotherapy. Read More
(Alliance News) - Markets in Europe got a boost on Wednesday, ahead of two key interest rate decisions, starting with the US Federal Reserve this evening. Read More
(Alliance News) - Stock prices in London were higher heading into Wednesday afternoon, with gains on the FTSE 100 largely broad-based, though a guidance hike could not push GSK into the green. Read More
(Alliance News) - GSK PLC on Wednesday raised its annual guidance after a strong second quarter but shares fell on a lowered outlook for its Vaccines arm and disappointing Shingrix sales. Read More
(Alliance News) - London's FTSE 100 is called to open higher on Wednesday, shaking off a poor day for US tech, ahead of a Federal Reserve interest rate decision. Read More
(Alliance News) - GSK PLC on Monday said its Arexvy offering received a "positive opinion" from the European Medicines Agency's Committee for Medicinal Products for Human Use. Read More
(Alliance News) - London's FTSE 100 is called to open higher on Monday, ahead of a trio of central bank decisions and more US earnings, including numbers from the likes of Apple and Microsoft. Read More
(Alliance News) - GSK PLC on Tuesday reported "positive" data for testing on three different treatments by ViiV Healthcare, its majority-owned specialist HIV company. Read More
(Alliance News) - The FTSE 100 opened higher in London on Friday morning, while other stocks remained downbeat, as a nationwide tech outage combined with gloomy retail sales data at the start of the day. Read More
(Alliance News) - GSK PLC on Friday said its treatment for relapsed or refractory multiple myeloma has been accepted for review by a European regulatory panel. Read More
(Alliance News) - Pharmaceutical company GSK PLC is set to move its global headquarters back to central London, ending more than two decades at its Brentford base. Read More
(Alliance News) - GSK PLC on Wednesday restructured an existing collaboration with CureVac NV into a new licensing agreement to take control of developing a number of flu and Covid drugs. Read More
